Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
The American Journal of Managed Care
|
January 4, 2018
Pharmacotherapeutic management of pseudobulbar affect
Jack J Chen
Therapeutic Advances in Neurological Disorders
|
January 11, 2014
Anxiety in Parkinson's disease: identification and management
Jack J Chen, Laura Marsh
Clinical Therapeutics
|
December 22, 2005
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease
Jack J Chen, Crystal Obering
Pharmacotherapy
|
June 26, 2013
Depression in Parkinson's disease: identification and management
Jack J Chen, Laura Marsh
Pharmacotherapy
|
February 13, 2013
Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer
Jack J Chen, Khashayar Dashtipour
Journal of Clinical Pharmacology
|
June 2, 2011
The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
Jack J Chen, Jayne R Wilkinson
Journal of Clinical Pharmacology
|
July 20, 2005
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease
Jack J Chen, David M Swope
Journal of Pharmacy Practice
|
September 19, 2019
Gagné's 9 Events of Instruction With Active Learning: Teaching Student Pharmacists How to Measure Blood Pressure
Jack J Chen, Herman Joseph Johannesmeyer
Pharmacotherapy
|
November 29, 2007
Pharmacotherapy for Parkinson's disease
Jack J Chen, David M Swope
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 6, 2006
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease
Jack J Chen, Anh-Vuong Ly
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
The American Journal of Managed Care
|
January 4, 2018
Pharmacotherapeutic management of pseudobulbar affect
Jack J Chen
Therapeutic Advances in Neurological Disorders
|
January 11, 2014
Anxiety in Parkinson's disease: identification and management
Jack J Chen, Laura Marsh
Clinical Therapeutics
|
December 22, 2005
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease
Jack J Chen, Crystal Obering
Pharmacotherapy
|
June 26, 2013
Depression in Parkinson's disease: identification and management
Jack J Chen, Laura Marsh
Pharmacotherapy
|
February 13, 2013
Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer
Jack J Chen, Khashayar Dashtipour
Journal of Clinical Pharmacology
|
June 2, 2011
The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
Jack J Chen, Jayne R Wilkinson
Journal of Clinical Pharmacology
|
July 20, 2005
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease
Jack J Chen, David M Swope
Journal of Pharmacy Practice
|
September 19, 2019
Gagné's 9 Events of Instruction With Active Learning: Teaching Student Pharmacists How to Measure Blood Pressure
Jack J Chen, Herman Joseph Johannesmeyer
Pharmacotherapy
|
November 29, 2007
Pharmacotherapy for Parkinson's disease
Jack J Chen, David M Swope
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 6, 2006
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease
Jack J Chen, Anh-Vuong Ly
Page
of 6